SOPHiA GENETICS SA

SOPH Nasdaq CIK: 0001840706

Company Information

Industry Services-Computer Processing & Data Preparation
SIC Code 7374
Entity Type other
SEC Category Accelerated filerEmerging growth company
State of Incorporation Switzerland
Business Address LA PIECE, CH-1180, ROLLE, V8, 00000
Mailing Address LA PIECE, CH-1180, ROLLE, V8, 00000
Phone 41 21 694 10 60
Fiscal Year End 1231
EIN 000000000

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 8, 2026 View on SEC
4/A Insider transaction amendment April 8, 2026 View on SEC
4 Insider stock transaction report April 8, 2026 View on SEC
4/A Insider transaction amendment April 8, 2026 View on SEC
4 Insider stock transaction report April 8, 2026 View on SEC
4/A Insider transaction amendment April 8, 2026 View on SEC
4/A Insider transaction amendment April 8, 2026 View on SEC
4 Insider stock transaction report April 8, 2026 View on SEC
4 Insider stock transaction report April 8, 2026 View on SEC
4/A Insider transaction amendment April 8, 2026 View on SEC

Annual Reports

20-F March 3, 2026
  • Achieved strong revenue growth of approximately 25% year-over-year to an estimated $55 million in FY2023, with projected 20-28% growth for FY2024.
  • Flagship SOPHiA DDM™ platform utilizes AI to analyze over 1.2 million genomic profiles, empowering data-driven medicine in oncology, rare diseases, and cardiology.
View Analysis

Insider Trading

SELL 9 insiders 28 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 7374)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.